{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:59:15Z","timestamp":1790420355849,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s40261-013-0090-0","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T09:04:19Z","timestamp":1370423059000},"page":"497-503","source":"Crossref","is-referenced-by-count":33,"title":["Treatment of Morton Neuroma with Botulinum Toxin A: A Pilot Study"],"prefix":"10.1007","volume":"33","author":[{"given":"Jos\u00e9 M.","family":"Climent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mond\u00e9jar-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodr\u00edguez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"D\u00edaz-Llopis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"G\u00f3mez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mart\u00edn-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"issue":"6","key":"90_CR1","first-page":"646","volume":"71","author":"H Hassouna","year":"2005","unstructured":"Hassouna H, Singh D. Morton\u2019s metatarsalgia: pathogenesis, aetiology and current management. Acta Orthop Belg. 2005;71(6):646\u201355.","journal-title":"Acta Orthop Belg"},{"key":"90_CR2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/107110079501601204","volume":"16","author":"GL Bennett","year":"1995","unstructured":"Bennett GL, Graham CE, Mauldin DM. Morton\u2019s interdigital neuroma: a comprehensive treatment protocol. Foot Ankle Int. 1995;16:760\u20133.","journal-title":"Foot Ankle Int"},{"issue":"1","key":"90_CR3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11420-006-9029-9","volume":"3","author":"CM Sofka","year":"2007","unstructured":"Sofka CM, Adler RS, Ciavarra GA, et al. Ultrasound-guided interdigital neuroma injections: short-term clinical outcomes after a single percutaneous injection: preliminary results. HSS J. 2007;3(1):44\u20139.","journal-title":"HSS J"},{"issue":"3","key":"90_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2005-921938","volume":"9","author":"M Zanetti","year":"2005","unstructured":"Zanetti M, Weishaupt D. MR imaging of the forefoot: Morton neuroma and differential diagnoses. Semin Musculoskelet Radiol. 2005;9(3):175\u201386.","journal-title":"Semin Musculoskelet Radiol"},{"key":"90_CR5","doi-asserted-by":"crossref","unstructured":"Thomson CE, Gibson JN, Martin D. Interventions for the treatment of Morton\u2019s neuroma. Cochrane Database Syst Rev. 2004;(3):CD003118.","DOI":"10.1002\/14651858.CD003118.pub2"},{"key":"90_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003086-198405000-00023","volume":"185","author":"J Greenfield","year":"1984","unstructured":"Greenfield J, Rea J Jr, et al. Morton\u2019s interdigital neuroma. Indications for treatment by local surgery. Clin Orthop Relat Res. 1984;185:142\u20134.","journal-title":"Clin Orthop Relat Res"},{"key":"90_CR7","doi-asserted-by":"crossref","unstructured":"Morton TG. The classic. A peculiar and painful affection of the fourth metatarso-phalangeal articulation. Thomas G. Morton, M.D. Clin Orthop Relat Res. 1979;142:4\u20139.","DOI":"10.1097\/00003086-197907000-00002"},{"issue":"4","key":"90_CR8","first-page":"319","volume":"58","author":"G Pasero","year":"2006","unstructured":"Pasero G, Marson P. Filippo Civinini (1805\u20131844) and the discovery of plantar neuroma [in Italian]. Reumatismo. 2006;58(4):319\u201322.","journal-title":"Reumatismo"},{"key":"90_CR9","doi-asserted-by":"crossref","unstructured":"Lee MJ, Kim S, Huh YM, et al. Morton neuroma: evaluated with ultrasonography and MR imaging. Korean J Radiol. 2007;8(2):148\u201355.","DOI":"10.3348\/kjr.2007.8.2.148"},{"key":"90_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/107110070502600711","volume":"26","author":"B Saygi","year":"2005","unstructured":"Saygi B, Yildirim Y, Saygi EK, et al. Morton\u2019s neuroma: comparative results of two conservative methods. Foot Ankle Int. 2005;26:556\u20139.","journal-title":"Foot Ankle Int"},{"key":"90_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1067-2516(99)80040-4","volume":"38","author":"GL Dockery","year":"1999","unstructured":"Dockery GL. The treatment of intermetatarsal neuromas with 4% alcohol sclerosing injections. J Foot Ankle Surg. 1999;38:403\u20138.","journal-title":"J Foot Ankle Surg"},{"key":"90_CR12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cuor.2005.07.004","volume":"19","author":"SK Singh","year":"2005","unstructured":"Singh SK, Ioli JP, Chiodo CP. The surgical treatment of Morton\u2019s neuroma. Curr Orthop. 2005;19:379\u201384.","journal-title":"Curr Orthop"},{"key":"90_CR13","doi-asserted-by":"crossref","unstructured":"Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve. 1997;Suppl 6:146\u201368.","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4"},{"key":"90_CR14","doi-asserted-by":"crossref","unstructured":"Costa J, Esp\u00edrito-Santo C, Borges A, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2004;(4):CD004315.","DOI":"10.1002\/14651858.CD004315.pub2"},{"issue":"11","key":"90_CR15","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1526-4637.2011.01245.x","volume":"12","author":"B Jabbari","year":"2011","unstructured":"Jabbari B, Machado D. Treatment of refractory pain with botulinum toxins: an evidence-based review. Pain Med. 2011;12(11):1594\u2013606.","journal-title":"Pain Med"},{"issue":"15","key":"90_CR16","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0b013e318232ab65","volume":"77","author":"RB Lipton","year":"2011","unstructured":"Lipton RB, Varon SF, Grosberg B, et al. Onabotulinum toxin A improves quality of life and reduces impact of chronic migraine. Neurology. 2011;77(15):1465\u201372.","journal-title":"Neurology"},{"issue":"7","key":"90_CR17","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0269215511426159","volume":"26","author":"IV D\u00edaz-Llopis","year":"2012","unstructured":"D\u00edaz-Llopis IV, Rodriguez-Ruiz CM, Mulet-Perry S, et al. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months. Clin Rehabil. 2012;26(7):594\u2013606.","journal-title":"Clin Rehabil"},{"issue":"12","key":"90_CR18","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/j.1526-4637.2010.00997.x","volume":"11","author":"C Argoff","year":"2010","unstructured":"Argoff C. The emerging use of botulinum toxins for the treatment of neuropathic pain. Pain Med. 2010;11(12):1750\u20132.","journal-title":"Pain Med"},{"key":"90_CR19","doi-asserted-by":"crossref","unstructured":"Ranoux D. Botulinum toxin and peripheral neuropathies: what should be expected? Rev Neurol (Paris). 2011;167(1):46\u201350.","DOI":"10.1016\/j.neurol.2010.11.001"},{"issue":"3 Suppl","key":"90_CR20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O\u2019Connor AB, Audette J. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3\u201314.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"90_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3344\/kjp.2011.24.1.1","volume":"24","author":"WS Sim","year":"2011","unstructured":"Sim WS. Application of botulinum toxin in pain management. Korean J Pain. 2011;24(1):1\u20136.","journal-title":"Korean J Pain."},{"issue":"4","key":"90_CR22","first-page":"259","volume":"23","author":"C Ruiz-Huete","year":"2008","unstructured":"Ruiz-Huete C, Bermejo PE. Toxina botul\u00ednica tipo A en el tratamiento del dolor neurop\u00e1tico en un caso de neuralgia postherp\u00e9tica. Neurolog\u00eda. 2008;23(4):259\u201362.","journal-title":"Neurolog\u00eda"},{"issue":"9","key":"90_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00044011-200626090-00004","volume":"26","author":"CP Tsai","year":"2006","unstructured":"Tsai CP, Liu CY, Lin KP, et al. Efficacy of botulinum toxin type A in the relief of Carpal tunnel syndrome: a preliminary experience. Clin Drug Investig. 2006;26(9):511\u20135.","journal-title":"Clin Drug Investig"},{"key":"90_CR24","doi-asserted-by":"crossref","unstructured":"Vanelderen P, Lataster A, Levy R, et al. Occipital neuralgia. Pain Pract. 2010;10(2):137\u201344.","DOI":"10.1111\/j.1533-2500.2009.00355.x"},{"issue":"17","key":"90_CR25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","volume":"72","author":"RY Yuan","year":"2009","unstructured":"Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology. 2009;72(17):1473\u20138.","journal-title":"Neurology"},{"issue":"3","key":"90_CR26","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","volume":"109","author":"WC Ngeow","year":"2010","unstructured":"Ngeow WC, Nair R. Injection of botulinum toxin type A (Botox) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(3):e47\u201350.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"90_CR27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","volume":"65","author":"EJ Piovesan","year":"2005","unstructured":"Piovesan EJ, Teive HG, Kowacs PA, et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65:1306\u20138.","journal-title":"Neurology"},{"issue":"5","key":"90_CR28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785\u201393.","journal-title":"Neurotoxicology"},{"issue":"4","key":"90_CR29","first-page":"211","volume":"54","author":"MJ Sirera-Vercher","year":"2010","unstructured":"Sirera-Vercher MJ, S\u00e1ez-Zamora P, Sanz-Amaro MD. Traducci\u00f3n y adaptaci\u00f3n transcultural al castellano y al valenciano del Foot Health Status Questionnaire. Rev Esp Cir Ortop Traumatol. 2010;54(4):211\u20139.","journal-title":"Rev Esp Cir Ortop Traumatol"},{"key":"90_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7547\/87507315-88-9-419","volume":"88","author":"PJ Bennett","year":"1998","unstructured":"Bennett PJ, Patterson C, Wearing S, et al. Development and validation of a questionnaire designed to measure foot-health status. J Am Podiatr Med Assoc. 1998;88:419\u201328.","journal-title":"J Am Podiatr Med Assoc"},{"issue":"2","key":"90_CR31","first-page":"224","volume":"73","author":"H Hassouna","year":"2007","unstructured":"Hassouna H, Singh D, Taylor H, et al. Ultrasound guided steroid injection in the treatment of interdigital neuralgia. Acta Orthop Belg. 2007;73(2):224\u20139.","journal-title":"Acta Orthop Belg"},{"issue":"5","key":"90_CR32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3113\/FAI.2008.0483","volume":"29","author":"M Markovic","year":"2008","unstructured":"Markovic M, Crichton K, Read JW, et al. Effectiveness of ultrasound-guided corticosteroid injection in the treatment of Morton\u2019s neuroma. Foot Ankle Int. 2008;29(5):483\u20137.","journal-title":"Foot Ankle Int"},{"key":"90_CR33","doi-asserted-by":"crossref","unstructured":"Mozena JD, Clifford JT. Efficacy of chemical neurolysis for the treatment of interdigital nerve compression of the foot: a retrospective study. J Am Podiatr Med Assoc. 2007;97(3):203\u20136.","DOI":"10.7547\/0970203"},{"key":"90_CR34","unstructured":"Magnan B, Marangon A, Frigo A, et al. Local phenol injection in the treatment of interdigital neuritis of the foot (Morton\u2019s neuroma). Chir Organi Mov. 2005;90(4):371\u20137."},{"issue":"3","key":"90_CR35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00330-003-2057-7","volume":"14","author":"E Fanucci","year":"2004","unstructured":"Fanucci E, Masala S, Fabiano S, et al. Treatment of intermetatarsal Morton\u2019s neuroma with alcohol injection under US guide: 10-month follow-up. Eur Radiol. 2004;14(3):514\u20138.","journal-title":"Eur Radiol"},{"issue":"6","key":"90_CR36","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2214\/AJR.06.1463","volume":"188","author":"RJ Hughes","year":"2007","unstructured":"Hughes RJ, Ali K, Jones H, et al. Treatment of Morton\u2019s neuroma with alcohol injection under sonographic guidance: follow-up of 101 cases. Am J Roentgenol. 2007;188(6):1535\u20139.","journal-title":"Am J Roentgenol"},{"issue":"2","key":"90_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AJP.0b013e3182264fe9","volume":"28","author":"H Wu","year":"2012","unstructured":"Wu H, Sultana R, Taylor KB, et al. A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine\/Depomedrol injection on residual and phantom limb pain: initial report. Clin J Pain. 2012;28(2):108\u201312.","journal-title":"Clin J Pain"},{"issue":"Suppl 1","key":"90_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2011.06.013","volume":"17","author":"KR Aoki","year":"2011","unstructured":"Aoki KR, Francis J. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism Relat Disord. 2011;17(Suppl 1):28\u201333.","journal-title":"Parkinsonism Relat Disord"},{"key":"90_CR39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00000542-199403000-00041","volume":"80","author":"MA Acquadro","year":"1994","unstructured":"Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin [letter]. Anesthesiology. 1994;80:705\u20136.","journal-title":"Anesthesiology"},{"key":"90_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(94)90048-5","volume":"59","author":"WP Cheshire","year":"1994","unstructured":"Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. 1994;59:65\u20139.","journal-title":"Pain"},{"key":"90_CR41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002060-200207000-00008","volume":"81","author":"T-S Kuan","year":"2002","unstructured":"Kuan T-S, Chen J-T, Chen S-M, Chien C-H, Hong C-Z. Effect of botulinum toxin on endplate noise in myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil. 2002;81:512\u201320.","journal-title":"Am J Phys Med Rehabil"},{"issue":"1\u20132","key":"90_CR42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pain.2006.05.001","volume":"125","author":"H Gobel","year":"2006","unstructured":"Gobel H, Heinze A, Reichel G, Hefter H, Benecke R. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blinded placebo-controlled multicentre study. Pain. 2006;125(1\u20132):82\u20138.","journal-title":"Pain"},{"key":"90_CR43","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007632-199808010-00009","volume":"23","author":"AH Wheeler","year":"1998","unstructured":"Wheeler AH, Goolkasian P, Gretz SS. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine. 1998;23:1662\u20137.","journal-title":"Spine"},{"issue":"Suppl 1","key":"90_CR44","first-page":"22","volume":"3","author":"SK Yue","year":"1995","unstructured":"Yue SK. Initial experience in the use of botulinum toxin A for the treatment of myofascial related muscle dysfunctions. J Musculoskelet Pain. 1995;3(Suppl 1):22.","journal-title":"J Musculoskelet Pain"},{"issue":"4","key":"90_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1533-2500.2007.00150.x","volume":"7","author":"L Kapural","year":"2007","unstructured":"Kapural L, Stillman M, Kapural M, et al. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series. Pain Pract. 2007;7(4):337\u201340.","journal-title":"Pain Pract"},{"issue":"Suppl 1","key":"90_CR46","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1177\/0883073803018001S0701","volume":"18","author":"AH Tilton","year":"2003","unstructured":"Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. J Child Neurol. 2003;18(Suppl 1):S50\u201366.","journal-title":"J Child Neurol."},{"issue":"5","key":"90_CR47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E Comp\u00e9rat","year":"2006","unstructured":"Comp\u00e9rat E, Reitz A, Delcourt A, Capron F, Denys P, Chartier-Kastler E. Histologic features in the urinary bladder wall affected from neurogenic overactivity: a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol. 2006;50(5):1058\u201364.","journal-title":"Eur Urol."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-013-0090-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0090-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0090-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T02:14:25Z","timestamp":1645668865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-013-0090-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1007\/s40261-013-0090-0","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,6]]}}}